BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22851646)

  • 21. Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers.
    Pfefferle AD; Agrawal YN; Koboldt DC; Kanchi KL; Herschkowitz JI; Mardis ER; Rosen JM; Perou CM
    Dis Model Mech; 2016 Jul; 9(7):749-57. PubMed ID: 27149990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neurofibromin 1 type I isoform predominance characterises female population affected by sporadic breast cancer: preliminary data.
    Marrero D; Peralta R; Valdivia A; De la Mora A; Romero P; Parra M; Mendoza N; Mendoza M; Rodriguez D; Camacho E; Duarte A; Castelazo G; Vanegas E; Garcia I; Vargas C; Arenas D; Jimenez F; Salcedo M
    J Clin Pathol; 2012 May; 65(5):419-23. PubMed ID: 22412049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
    Xu J; Ismat FA; Wang T; Yang J; Epstein JA
    Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decoding NF1 Intragenic Copy-Number Variations.
    Hsiao MC; Piotrowski A; Callens T; Fu C; Wimmer K; Claes KB; Messiaen L
    Am J Hum Genet; 2015 Aug; 97(2):238-49. PubMed ID: 26189818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.
    Chohan H; Esfandiarei M; Arman D; Van Raamsdonk CD; van Breemen C; Friedman JM; Jett KA
    PLoS One; 2018; 13(12):e0208835. PubMed ID: 30571760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenic Mutations Associated with Legius Syndrome Modify the Spred1 Surface and Are Involved in Direct Binding to the Ras Inactivator Neurofibromin.
    Führer S; Tollinger M; Dunzendorfer-Matt T
    J Mol Biol; 2019 Sep; 431(19):3889-3899. PubMed ID: 31401120
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Hayashi T; Desmeules P; Smith RS; Drilon A; Somwar R; Ladanyi M
    Clin Cancer Res; 2018 Mar; 24(6):1436-1447. PubMed ID: 29127119
    [No Abstract]   [Full Text] [Related]  

  • 28. The landscape of chromosomal aberrations in breast cancer mouse models reveals driver-specific routes to tumorigenesis.
    Ben-David U; Ha G; Khadka P; Jin X; Wong B; Franke L; Golub TR
    Nat Commun; 2016 Jul; 7():12160. PubMed ID: 27374210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation Screening of Her-2, N-ras and Nf1 Genes in Brain Tumor Biopsies.
    Yapijakis C; Adamopoulou M; Tasiouka K; Voumvourakis C; Stranjalis G
    Anticancer Res; 2016 Sep; 36(9):4607-11. PubMed ID: 27630302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
    Su W; Xing R; Guha A; Gutmann DH; Sherman LS
    Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Merlin cooperates with neurofibromin and Spred1 to suppress the Ras-Erk pathway.
    Cui Y; Ma L; Schacke S; Yin JC; Hsueh YP; Jin H; Morrison H
    Hum Mol Genet; 2021 Feb; 29(23):3793-3806. PubMed ID: 33331896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice.
    Ismat FA; Xu J; Lu MM; Epstein JA
    J Clin Invest; 2006 Sep; 116(9):2378-84. PubMed ID: 16906226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers.
    Fougner C; Bergholtz H; Kuiper R; Norum JH; Sørlie T
    Breast Cancer Res; 2019 Jul; 21(1):85. PubMed ID: 31366361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.
    Anastasaki C; Woo AS; Messiaen LM; Gutmann DH
    Hum Mol Genet; 2015 Jun; 24(12):3518-28. PubMed ID: 25788518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurofibromatosis 1: closing the GAP between mice and men.
    Dasgupta B; Gutmann DH
    Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.
    Dasgupta B; Dugan LL; Gutmann DH
    J Neurosci; 2003 Oct; 23(26):8949-54. PubMed ID: 14523097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras.
    Hannan F; Ho I; Tong JJ; Zhu Y; Nurnberg P; Zhong Y
    Hum Mol Genet; 2006 Apr; 15(7):1087-98. PubMed ID: 16513807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.
    Dasgupta B; Yi Y; Chen DY; Weber JD; Gutmann DH
    Cancer Res; 2005 Apr; 65(7):2755-60. PubMed ID: 15805275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
    Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
    Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA copy number aberrations and disruption of the p16Ink4a/Rb pathway in radiation-induced and spontaneous rat mammary carcinomas.
    Iizuka D; Imaoka T; Takabatake T; Nishimura M; Kakinuma S; Nishimura Y; Shimada Y
    Radiat Res; 2010 Aug; 174(2):206-15. PubMed ID: 20681787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.